Drug
Nicoderm Patch
Nicoderm Patch is a pharmaceutical drug with 3 clinical trials. Historical success rate of 66.7%.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
66.7%
Based on 2 completed trials
Completion Rate
67%(2/3)
Active Trials
0(0%)
Results Posted
50%(1 trials)
Terminated
1(33%)
Phase Distribution
Ph phase_4
3
100%
Phase Distribution
0
Early Stage
0
Mid Stage
3
Late Stage
Phase Distribution3 total trials
Phase 4Post-market surveillance
3(100.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
66.7%
2 of 3 finished
Non-Completion Rate
33.3%
1 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(2)
Terminated(1)
Detailed Status
Completed2
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
66.7%
Most Advanced
Phase 4
Trials by Phase
Phase 43 (100.0%)
Trials by Status
completed267%
terminated133%
Recent Activity
0 active trials
Showing 3 of 3
completedphase_4
Self-directed Titrated Transdermal Nicotine Patch Versus Standard Treatment for Smoking Cessation
NCT01622998
terminatedphase_4
Effect of Pre-op NRT on Peri-operative Complications and Long-term Abstinence: A Pilot Trial in Patients Undergoing CABG Surgery
NCT02918500
completedphase_4
Electrophysiologic Measures of Treatment Response in Alzheimer Disease
NCT00018278
Clinical Trials (3)
Showing 3 of 3 trials
NCT01622998Phase 4
Self-directed Titrated Transdermal Nicotine Patch Versus Standard Treatment for Smoking Cessation
NCT02918500Phase 4
Effect of Pre-op NRT on Peri-operative Complications and Long-term Abstinence: A Pilot Trial in Patients Undergoing CABG Surgery
NCT00018278Phase 4
Electrophysiologic Measures of Treatment Response in Alzheimer Disease
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3